VP Bruce Church to speak on how the REFS™ platform was built and how it can enable previously inaccessible individual-level decision-making across many verticals.…

Eric Schadt, the chair of the GNS Healthcare Scientific Advisory Board and CSO of Pacific Biosciences, is profiled by Esquire Magazine in an article entitled “Adventures in Extreme Science”…

GNS Healthcare announces the publication of results from a study focused on identifying novel drug targets for the one-third of rheumatoid arthritis patients who do not respond to leading anti-TNF therapies.

CEO Colin Hill will appear on a panel discussing novel strategies for drug development in oncology.…

GNS Healthcare has announced that it has entered into a joint venture with Berg Biosystems, focusing on drug repositioning through unlocking drug mechanisms.

CEO Colin Hill will appear on a panel entitled “Monetizing our Information — The Applications”.…

GNS Healthcare has announced that it has entered into a contract with the National Cancer Institute (NCI) and SAIC-Frederick to unravel the mechanisms of several well-known cancer treatments.

GNS Healthcare EVP Dr. Iya Khalil will give a talk entitled “The Implications of Next-Wave Innovation in Sequencing and Computation” together with Pacific Biosciences CSO and GNS Scientific Advisory Board co-chair Dr. Eric Schadt.…

GNS announces a two-year collaboration with Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School. The goal of the collaboration is to identify biomarkers to predict patient response to asthma therapies and to discover new biology that may lead to better treatments for asthma.

Colin Hill to receive the Water Cove Award, which recognizes individuals who have made a major, specific impact on accelerating the pace of MS research, at the Accelerated Cures Project’s annual Opening Doors to Cure MS Recognition Dinner.…